Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
01
2021
accepted:
18
03
2021
entrez:
9
4
2021
pubmed:
10
4
2021
medline:
18
9
2021
Statut:
epublish
Résumé
The search for immune correlates of protection against Mycobacterium tuberculosis (MTB) infection in humans is limited by the focus on peripheral blood measures. Bronchoalveolar lavage (BAL) can safely be done and provides insight into cellular function in the lung where infection is first established. In this study, blood and lung samples were assayed to determine if heavily MTB exposed persons who resist development of latent MTB infection (RSTR) vs those who develop latent MTB infection (LTBI), differ in the make-up of resident BAL innate and adaptive immune cells. Bronchoscopy was performed on 21 healthy long-term Ugandan RSTR and 25 LTBI participants. Immune cell distributions in BAL and peripheral blood were compared by differential cell counting and flow cytometry. The bronchoscopy procedure was well tolerated with few adverse reactions. Differential macrophage and lymphocyte frequencies in BAL differed between RSTR and LTBI. When corrected for age, this difference lost statistical significance. BAL CD4+ and CD8+ T cells were almost entirely composed of effector memory T cells in contrast to PBMC, and did not differ between RSTR and LTBI. BAL NKT, γδ T cells and NK cells also did not differ between RTSR and LTBI participants. There was a marginally significant increase (p = 0.034) in CD8 T effector memory cells re-expressing CD45RA (TEMRA) in PBMC of LTBI vs RSTR participants. This observational case-control study comparing unstimulated BAL from RSTR vs LTBI, did not find evidence of large differences in the distribution of baseline BAL immune cells. PBMC TEMRA cell percentage was higher in LTBI relative to RSTR suggesting a role in the maintenance of latent MTB infection. Functional immune studies are required to determine if and how RSTR and LTBI BAL immune cells differ in response to MTB.
Sections du résumé
BACKGROUND
The search for immune correlates of protection against Mycobacterium tuberculosis (MTB) infection in humans is limited by the focus on peripheral blood measures. Bronchoalveolar lavage (BAL) can safely be done and provides insight into cellular function in the lung where infection is first established. In this study, blood and lung samples were assayed to determine if heavily MTB exposed persons who resist development of latent MTB infection (RSTR) vs those who develop latent MTB infection (LTBI), differ in the make-up of resident BAL innate and adaptive immune cells.
METHODS
Bronchoscopy was performed on 21 healthy long-term Ugandan RSTR and 25 LTBI participants. Immune cell distributions in BAL and peripheral blood were compared by differential cell counting and flow cytometry.
RESULTS
The bronchoscopy procedure was well tolerated with few adverse reactions. Differential macrophage and lymphocyte frequencies in BAL differed between RSTR and LTBI. When corrected for age, this difference lost statistical significance. BAL CD4+ and CD8+ T cells were almost entirely composed of effector memory T cells in contrast to PBMC, and did not differ between RSTR and LTBI. BAL NKT, γδ T cells and NK cells also did not differ between RTSR and LTBI participants. There was a marginally significant increase (p = 0.034) in CD8 T effector memory cells re-expressing CD45RA (TEMRA) in PBMC of LTBI vs RSTR participants.
CONCLUSION
This observational case-control study comparing unstimulated BAL from RSTR vs LTBI, did not find evidence of large differences in the distribution of baseline BAL immune cells. PBMC TEMRA cell percentage was higher in LTBI relative to RSTR suggesting a role in the maintenance of latent MTB infection. Functional immune studies are required to determine if and how RSTR and LTBI BAL immune cells differ in response to MTB.
Identifiants
pubmed: 33836031
doi: 10.1371/journal.pone.0249477
pii: PONE-D-21-01604
pmc: PMC8034721
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0249477Subventions
Organisme : NIAID NIH HHS
ID : 75N93019C00071
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124348
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI115642
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
PLoS One. 2012;7(4):e36046
pubmed: 22545156
J Immunol. 2017 Feb 15;198(4):1748-1758
pubmed: 28069807
Clin Infect Dis. 2019 May 2;68(10):1705-1712
pubmed: 30165605
Eur Clin Respir J. 2016 Feb 03;3:29511
pubmed: 26847517
PLoS One. 2017 Apr 17;12(4):e0175844
pubmed: 28414762
Am J Respir Cell Mol Biol. 2003 Jul;29(1):117-23
pubmed: 12821447
PLoS One. 2017 Nov 10;12(11):e0187882
pubmed: 29125874
Am J Epidemiol. 2018 Jul 1;187(7):1477-1489
pubmed: 29304247
Front Immunol. 2018 May 23;9:1119
pubmed: 29875774
Int J Tuberc Lung Dis. 2009 Jan;13(1):39-46
pubmed: 19105877
PLoS One. 2017 Aug 24;12(8):e0183846
pubmed: 28837654
J Clin Invest. 2009 May;119(5):1167-77
pubmed: 19381021
Nat Med. 2019 Jun;25(6):977-987
pubmed: 31110348
Am J Respir Cell Mol Biol. 2005 Jul;33(1):48-55
pubmed: 15778493
Am J Respir Crit Care Med. 2011 Mar 15;183(6):696-707
pubmed: 21075901